Sell PLTR by Nov 17, 2026.

Here are some facts that may help you decide whether to buy, hold, or sell. ZERO insider purchase - distribution continues ($29.5M extracted by the CTO). Continuous Dilution (SBC): Stock-Based Compensation remains a structural point of friction, with $265 million of SBC reported in the last quarter, continuing to dilute value for existing shareholders. Risk to the UK NHS Contract: Major concerns surround the non-renewal of the contract with the UK's National Health Service (NHS) (valued at approximately $440 million), …